Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors

被引:21
|
作者
Abdellatif, Khaled R. A. [1 ,2 ]
Abdelgawad, Mohamed A. [1 ,3 ]
Labib, Madlen B. [1 ]
Zidan, Taha H.
机构
[1] Beni Suef Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Bani Suwayf 62514, Egypt
[2] Ibn Sina Natl Coll Med Studies, Dept Pharmaceut Sci, Jeddah, Saudi Arabia
[3] Aljouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka, Aljouf, Saudi Arabia
关键词
Anti-inflammatory; Imidazoline; Pyrazole; Selective COX-2 inhibitor; DONOR ESTER PRODRUGS; ANTIINFLAMMATORY EVALUATION; CYCLOOXYGENASE INHIBITION; DESIGN;
D O I
10.1002/ardp.201600386
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New series of diarylpyrazoles 8a-f and triarylimidazoline-5-ones 11a-g were synthesized and evaluated for their in vitro cyclooxygenase-1 (COX-1) and COX-2 inhibitory activity and in vivo anti-inflammatory activity. The synthesized compounds showed good selectivity for COX-2; compounds 8a, 8d, 8f, 11a, and 11c exhibited the highest COX-2 selectivity indexes (SI=4.77-5.43) compared to the reference drug celecoxib (SI=7.8). All compounds showed good in vivo anti-inflammatory activity, especially compounds 8a, 8f, 11c, and 11d, which also showed some similarities to the time interval pattern of celecoxib at all different time intervals (1, 3, and 6h).
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors
    Grover, Jagdeep
    Kumar, Vivek
    Singh, Vikram
    Bairwa, Khemraj
    Sobhia, M. Elizabeth
    Jachak, Sanjay M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 80 : 47 - 56
  • [32] Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents
    Firke, Sandip D.
    Bari, Sanjay B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 5273 - 5281
  • [33] Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors
    Abdellatif, Khaled R. A.
    Abdelgawad, Mohamed A.
    Labib, Madlen B.
    Zidan, Taha H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) : 5787 - 5791
  • [34] Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation
    Tietz, Ole
    Kaur, Jatinder
    Bhardwaj, Atul
    Wuest, Frank R.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (30) : 7250 - 7257
  • [35] Design, Synthesis, Computational and Biological Evaluation of Two New Series of 1, 3-and 1,6-dihydroxy Xanthone Derivatives as Selective COX-2 Inhibitors
    Gogoi, Urvashee
    Das, Aparoop
    Pathak, Manash Pratim
    Chattopadhyay, Pronobesh
    Johari, Surabhi
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (09) : 884 - 914
  • [36] Synthesis and biological activity of annulated pyrazoles as selective COX-2 inhibitors. I.
    Kim, HH
    Park, JG
    Moon, TC
    Chang, HW
    Jahng, Y
    ARCHIVES OF PHARMACAL RESEARCH, 1999, 22 (04) : 372 - 379
  • [37] Synthesis and biological activity of annulated pyrazoles as selective COX-2 inhibitors. I.
    Hyun Hee Kim
    Jae Gyu Park
    Tae Chul Moon
    Hyun Wook Chang
    Yurngdong Jahng
    Archives of Pharmacal Research, 1999, 22 : 372 - 379
  • [38] Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
    Badrey, Mohamed G.
    Abdel-Aziz, Hassan M.
    Gomha, Sobhi M.
    Abdalla, Mohamed M.
    Mayhoub, Abdelrahman S.
    MOLECULES, 2015, 20 (08) : 15287 - 15303
  • [39] Arylidene analogues as selective COX-2 inhibitors: synthesis, characterization,in silicoandin vitrostudies
    Namera, Dipti L.
    Thakkar, Sampark S.
    Thakor, Parth
    Bhoya, Umed
    Shah, Anamik
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (18) : 7150 - 7159
  • [40] Pyridazine derivatives as selective COX-2 inhibitors: A review on recent updates
    Ewieda, Sara Y.
    Ahmed, Eman M.
    Hassan, Rasha A.
    Hassan, Marwa S. A.
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (08) : 1595 - 1623